Nachrichten

Baylis Medical is closely monitoring and responding to the COVID-19 crisis occurring around the world. We have put measures in place to continue supporting physicians and their patients, while ensuring the health and safety of our employees.

Baylis Medical is honoured to be recognized as one of Canada’s Best Managed Companies for the third consecutive year.

Baylis Medical is pleased to announce that it has won the Employee Recommended Workplace designation for 2020. The designation, which recognizes employers based on excellence in achieving a healthy, engaged and productive workforce, is based entirely on survey feedback from current employees.

A study has found that use of Baylis Medical’s SureFlex Steerable Guiding Sheath results in greater contact force stability for radiofrequency ablations in pulmonary vein isolations. Stable contact force has been linked to more effective ablations, a therapy in which radiofrequency energy is used to create a lesion in cardiac tissue to restore proper heart rhythm.

Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped wire, which acts as both puncture device and exchange rail. The puncture wire features Baylis’ signature RF puncture technology, which facilitates controlled and precise transseptal procedures.

A randomized controlled trial has found that use of Baylis Medical’s NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle.